Estrogen Receptor-beta (Phospho-Ser105) DNA-Binding ELISA Kit

Order Estrogen Receptor-beta Phospho-Ser105 DNA-Binding ELISA Kit 01015810759 at Gentaur Estrogen Receptor-beta (Phospho-Ser105) DNA-Binding

Contact

Estrogen Receptor-beta (Phospho-Ser105) DNA-Binding ELISA Kit

Size

96 Tests

Catalog no.

EKA52116

Price

701 EUR

 

Details

Research Area

NA

Quality Systems

NA

Stability

NA

Sensitivity

NA

Cross Activity

NA

Specificity

NA

Precision

NA

Assay Type

NA

Storage Temperature

4°C

Assay Time

6 hours

Shipping Conditions

Ice packs

Sample Type

Cell lysate

Species Reactivity

Human, Mouse

Estimated Turnaround Time

3-6 business days

Detection Method

Colorimetric 450 nm

Detection Range

10-30 ug of total protein/well

Target Name

Estrogen Receptor-beta (Phospho-Ser105)

Target's alterntive name

ESR2; ESTRB; Estrogen receptor beta; NR3A2

Application

For research use only. Not for diagnostic procedures.

Test

ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED

Precaution of Use

The Stop Solution is acidic. Do not allow to contact skin or eyes.

Shelf life

Use Estrogen Receptor-beta (Phospho-Ser105) DNA-Binding ELISA Kit before 6 months

Properties

E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays

Test Principle

The Estrogen Receptor-beta (Phospho-Ser105) DNA-Binding ELISA Kit qualitatively detects endogenous Estrogen Receptor-beta only when phosphorylated at Ser105.

Description

The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.